COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes()

Women with multiple sclerosis (MS) are often of childbearing age. Thirty-six women with MS who were pregnant (n = 27) or within 6 weeks postpartum (n = 9) were reported in the North American COViMS registry and their COVID-19 outcomes were described. One pregnant and one postpartum woman were hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Salter, Amber, Cross, Anne H., Cutter, Gary R., Fox, Robert J., Li, David K.B., Bebo, Bruce, Halper, June, Kanellis, Pamela, Rammohan, Kottil, Newsome, Scott D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252864/
https://www.ncbi.nlm.nih.gov/pubmed/35839562
http://dx.doi.org/10.1016/j.msard.2022.104028
Descripción
Sumario:Women with multiple sclerosis (MS) are often of childbearing age. Thirty-six women with MS who were pregnant (n = 27) or within 6 weeks postpartum (n = 9) were reported in the North American COViMS registry and their COVID-19 outcomes were described. One pregnant and one postpartum woman were hospitalized. No deaths occurred. To compare COVID-19 clinical outcomes in pregnant and postpartum females with females who were not pregnant or postpartum, a 1:2 propensity score match was performed. While not powered to detect small differences, it was reassuring that no increased risks for those with MS who were pregnant/postpartum were revealed.

Ejemplares similares